Biggest changeIncome Tax Benefit Income tax benefit consists of income taxes related to federal and state jurisdictions in which we conduct business. 72 Table of Contents Results of Operations The table below presents our consolidated statements of operations for the following periods: Year Ended December 31, 2024 2023 (as restated) 2022 (as restated) Revenues $ 158,236 $ 155,164 $ 155,011 Cost of revenues 113,016 114,563 112,018 Gross margin 45,220 40,601 42,993 Operating expenses: Selling, general and administrative 80,040 71,057 84,775 Research and development 10,863 5,035 8,393 Restructuring charges 1,287 822 4,203 Transaction expenses 1,450 2,721 2,605 Goodwill impairment 85,000 — 53,544 Operating loss (133,420) (39,034) (110,527) Net increase (decrease) in fair value of derivatives 107,658 7,361 (21,387) Loss on extinguishment of debt 31,272 — — Interest expense 25,647 24,877 24,092 Other (income) expense (2,194) (393) 19 Loss before taxes (295,803) (70,879) (113,251) Income tax benefit (256) (222) (1,884) Net loss $ (295,547) $ (70,657) $ (111,367) Comparison of the Year Ended December 31, 2024, 2023 and 2022 Revenues Year Ended December 31, Year-Over-Year Change 2024 2023 2022 2024 vs 2023 2023 vs 2022 Revenues $ 158,236 $ 155,164 $ 155,011 $ 3,072 2.0 % $ 153 0.1 % Revenues increased by $3.1 million during the year ended December 31, 2024 as compared to the year ended December 31, 2023.
Biggest changeResults of Operations The table below presents our consolidated statements of operations and comprehensive loss for the following periods: Years Ended December 31, 2025 2024 2023 Revenues $ 127,672 $ 158,236 $ 155,164 Cost of revenues 99,194 113,016 114,563 Gross margin 28,478 45,220 40,601 Operating expenses: Selling, general and administrative 95,132 80,040 71,057 Research and development 16,752 10,863 5,035 Restructuring charges 4,370 1,287 822 Transaction expenses 2,082 1,450 2,721 Impairment of long-lived assets 53,403 — — Goodwill impairment 70,636 85,000 — Operating loss (213,897) (133,420) (39,034) Interest expense 18,116 25,647 24,877 Interest income (13,253) (2,293) (392) Net increase in fair value of derivatives 92,794 107,658 7,361 Loss on extinguishment of debt 2,577 31,272 — Other expense (income), net 1,505 99 (1) Loss before taxes (315,636) (295,803) (70,879) Income tax benefit (21,722) (256) (222) Net loss $ (293,914) $ (295,547) $ (70,657) Comparison of the Years Ended December 31, 2025, 2024, and 2023 Revenues Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 Revenues $ 127,672 $ 158,236 $ 155,164 $ (30,564) (19.3) % $ 3,072 2.0 % Revenues decreased by $30.6 million during the year ended December 31, 2025 as compared to the year ended December 31, 2024 primarily due to lower volume on the Army programs and significant one time contracts during the year ended December 31, 2024, that did not recur during the year ended December 31, 2025.
On December 19, 2024, the Company entered into privately negotiated exchange agreements (each, an “ Exchange Agreement ”) with a limited number of holders of the Company’s existing 2026 Convertible Notes, to exchange the 2026 Convertible Notes for new senior secured convertible notes due 2029 (the “2029 Convertible Notes ”, together with the 2026 Convertible Notes, the “ Convertible Notes ”).
On December 19, 2024, the Company entered into privately negotiated exchange agreements (each, an “ Exchange Agreement ”) with a limited number of holders of the Company’s existing 2026 Convertible Notes, to exchange the existing convertible notes for new senior secured convertible notes due 2029 (the “2029 Convertible Notes ”, together with the 2026 Convertible Notes, the “ Convertible Notes ”).
Investing activities For the year ended December 31, 2024, net cash provided by investing activities was $2.8 million, primarily consisting of cash acquired from the Pangiam acquisition of $13.9 million, partially offset by capitalized software development costs of $10.6 million.
For the year ended December 31, 2024, net cash provided by investing activities was $2.8 million, primarily consisting of cash acquired from the Pangiam acquisition of $13.9 million, partially offset by capitalized software development costs of $10.6 million.
Financing activities For the year ended December 31, 2024, net cash provided by financing activities was $52.5 million, primarily consisting of the net proceeds from the issuance of shares pursuant to the exercise of the PIPE warrants and RDO warrants of $53.8 million, partially offset by the payment of taxes related to net share settlement of equity awards $2.4 million and the net repayment of $0.4 million related to the 2023 D&O Financing Loan.
For the year ended December 31, 2024, net cash provided by financing activities was $52.5 million, primarily consisting of the net proceeds from the issuance of shares pursuant to the exercise of the PIPE warrants and RDO warrants of $53.8 million, partially offset by the payment of taxes related to net share settlement of equity awards $2.4 million and the net repayment of $0.4 million related to the 2023 D&O Financing Loan.
Within each income approach method, a tax amortization benefit is included, which represents the tax benefit resulting from the amortization of that intangible asset depending on the tax jurisdiction where the intangible asset is held. Finite-lived intangible assets are reported at cost, net of accumulated amortization, and are amortized on a straight-line basis over their estimated useful lives.
Within each income approach method, a tax amortization benefit is included, which represents the tax benefit resulting from the amortization of that intangible asset depending on the tax jurisdiction where the intangible asset is held. Finite-lived intangible assets are reported at cost, net of accumulated amortization and impairment, and are amortized on a straight-line basis over their estimated useful lives.
The discussion and analysis of financial condition and results of operations of BigBear.ai is organized as follows: • Business Overview : This section provides a general description of BigBear.ai’s business, our priorities and the trends affecting our industry in order to provide context for management’s discussion and analysis of our financial condition and results of operations. • Recent Developments : This section provides recent developments that we believe are necessary to understand our financial condition and results of operations. • Results of Operations : This section provides a discussion of our results of operations for the year ended December 31, 2024, December 31, 2023 and December 31, 2022. • Liquidity and Capital Resources : This section provides an analysis of our ability to generate cash and to meet existing or reasonably likely future cash requirements. • Critical Accounting Policies and Estimates : This section discusses the accounting policies and estimates that we consider important to our financial condition and results of operations and that require significant judgment and estimates on the part of management in their application.
The discussion and analysis of financial condition and results of operations of BigBear.ai is organized as follows: • Business Overview : This section provides a general description of BigBear.ai’s business, our priorities and the trends affecting our industry in order to provide context for management’s discussion and analysis of our financial condition and results of operations. • Recent Developments : This section provides recent developments that we believe are necessary to understand our financial condition and results of operations. • Results of Operations : This section provides a discussion of our results of operations for the year ended December 31, 2025, December 31, 2024 and December 31, 2023. • Liquidity and Capital Resources : This section provides an analysis of our ability to generate cash and to meet existing or reasonably likely future cash requirements. • Critical Accounting Policies and Estimates : This section discusses the accounting policies and estimates that we consider important to our financial condition and results of operations and that require significant judgment and estimates on the part of management in their application.
Additional risks for goodwill across all reporting units include, but are not limited to: • our failure to reach our internal forecasts could impact our ability to achieve our forecasted levels of cash flows and reduce the estimated discounted value of our reporting units; • adverse technological events that could impact our performance; • volatility in equity and debt markets resulting in higher discount rates; and • significant adverse changes in the regulatory environment or markets in which we operate.
Additional risks for goodwill across our reporting unit include, but are not limited to: • our failure to reach our internal forecasts could impact our ability to achieve our forecasted levels of cash flows and reduce the estimated discounted value of our reporting units; • adverse technological events that could impact our performance; • volatility in equity and debt markets resulting in higher discount rates; and • significant adverse changes in the regulatory environment or markets in which we operate.
While these conflicts are still evolving and the eventual outcome remains highly uncertain, we do not believe that these events will have a material impact on our business and results of operations. However, if these conflicts worsen, leading to greater disruptions and uncertainty within the technology industry or global economy, our business and results of operations could be negatively impacted.
While these challenges are still evolving and the eventual outcome remains highly uncertain, we do not believe that these events will have a material impact on our business and results of operations. However, if these challenges worsen, leading to greater disruptions and uncertainty within the technology industry or global economy, our business and results of operations could be negatively impacted.
Derivatives Derivatives are accounted for in accordance with the guidance of ASC 815, Derivatives and Hedging (“ ASC 815 ”), under which the 2029 Notes Conversion Option, the 2026 Notes Conversion Option, IPO private warrants, Private Placement (“ PIPE ”) warrants, warrants issued under the registered direct offering (“ RDO warrants ”), and the Written Put Option, do not meet the criteria for equity treatment and are classified as liabilities measured at fair value.
Derivatives Derivatives are accounted for in accordance with the guidance of ASC 815, Derivatives and Hedging (“ ASC 815 ”), under which the 2029 Notes Conversion Option, the 2026 Notes Conversion Option, IPO private warrants, Private Placement (“ PIPE ”) warrants, and warrants issued under the registered direct offering (“ RDO warrants ”) do not meet the criteria for equity treatment and are classified as liabilities measured at fair value.
We refer to this as Unpriced Unexercised Options. We define backlog in these categories to provide the reader with additional context as to the nature of our backlog and so that the reader can understand the varying degrees of risk, uncertainty, and where applicable, management’s estimates and judgements used in determining backlog at the end of a period.
We refer to this as Unpriced Unexercised Options. We define backlog in these categories to provide the reader with additional context as to the nature of our backlog and so that the reader can understand the varying degrees of risk, uncertainty, and where applicable, management’s estimates and judgments used in determining backlog at the end of a period.
We generate revenue from providing both software and services to our customers. Cost of Revenues 71 Table of Contents Cost of revenues primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing the services described above as well as allocated overhead and other direct costs.
We generate revenue from providing both software and services to our customers. 69 Table of Contents Cost of revenues Cost of revenues primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing the services described above, as well as allocated overhead and other direct costs.
In addition, our significant accounting policies, including critical accounting policies, are summarized in Note 3—Summary of Significant Accounting Policies to the accompanying consolidated financial statements included in this Annual Report on Form 10-K. Business Overview Our mission is to help deliver clarity for the world’s most complex decisions.
In addition, our significant accounting policies, including critical accounting policies, are summarized in Note 2—Summary of Significant Accounting Policies to the accompanying consolidated financial statements included in this Annual Report on Form 10-K. Business Overview Our mission is to help deliver clarity for the world’s most complex decisions.
For the critical accounting estimates used in preparing our consolidated financial statements, we make assumptions and judgments that can have a significant impact on revenue and expenses in our consolidated statements of operations , as well as, on the value of certain assets and liabilities on our consolidated balance sheets.
For the critical accounting estimates used in preparing our consolidated financial statements, we make assumptions and judgments that can have a significant impact on revenue and expenses in our consolidated statements of operations and comprehensive loss , as well as, on the value of certain assets and liabilities on our consolidated balance sheets.
BigBear.ai is a leading provider of Edge AI-powered decision intelligence solutions for national security, supply chain management and digital identity. Customers and 69 Table of Contents partners rely on BigBear.ai’s predictive analytics capabilities in highly complex, distributed, mission-based operating environments. We are a technology-led solutions organization, providing both software and services to our customers.
BigBear.ai is a leading provider of Edge AI-powered decision intelligence solutions for national security, supply chain management and digital identity. Customers and partners rely on BigBear.ai’s predictive analytics capabilities in highly complex, distributed, mission-based operating environments. We are a technology-led solutions organization, providing both software and services to our customers.
On February 5, 2025, the Company entered into a warrant exercise agreement with an existing accredited investor to exercise in full an outstanding Common Stock Purchase Warrant to purchase up to an aggregate of 5,800,000 shares of the Company’s common stock.
On February 5, 2025, the Company entered into a warrant exercise agreement with an existing accredited investor to exercise in full an outstanding Common Stock Purchase Warrant, the 2024 RDO warrant, to purchase up to an aggregate of 5,800,000 shares of the Company’s common stock.
When adjustments in estimated contract costs are identified, such revisions may result in current period adjustments to earnings applicable to performance in prior periods. 86 Table of Contents Impairment of Long-Lived Assets The Company evaluates the recoverability of the carrying value of long-lived assets whenever events or circumstances indicate the carrying amount may not be recoverable.
When adjustments in estimated contract costs are identified, such revisions may result in current period adjustments to earnings applicable to performance in prior periods. Impairment of Long-Lived Assets The Company evaluates the recoverability of the carrying value of long-lived assets whenever events or circumstances indicate the carrying amount may not be recoverable.
The following table presents the carrying amounts and fair values associated with the Convertible Notes as of December 31, 2024. The fair value of the Convertible Notes is considered to be a Level 3 fair value measurement.
The following table presents the carrying amounts and fair values associated with the Convertible Notes as of December 31, 2025. The fair value of the Convertible Notes is considered to be a Level 3 fair value measurement.
We evaluate the recoverability of our intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the intangible assets are expected to generate.
We evaluate the recoverability of our intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is measured by a comparison of the 83 Table of Contents carrying amounts to the future undiscounted cash flows the intangible assets are expected to generate.
Public warrants meet the criteria for equity classification. The Company remeasures these derivatives at fair value at each reporting period with changes in fair value recognized in the consolidated statements of operations. Equity-based Compensation Pursuant to ASC 718, Compensation – Stock Compensation , equity-based awards are measured at fair value on the grant date.
Public warrants meet the criteria for equity classification. The Company remeasures these derivatives at fair value at each reporting period with changes in fair value recognized in the consolidated statements of operations and comprehensive loss. Equity-based Compensation Pursuant to ASC 718, Compensation – Stock Compensation , equity-based awards are measured at fair value on the grant date.
The Company 85 Table of Contents considers the nature of these contracts and the types of solutions and services provided when determining the proper accounting for a particular contract. The Company performs under various types of contracts, which generally include firm-fixed-price (“ FFP ”), time-and-materials (“ T&M ”), and cost-reimbursable contracts.
The Company considers the nature of these contracts and the types of solutions and services provided when determining the proper accounting for a particular contract. The Company performs under various types of contracts, which generally include firm-fixed-price (“ FFP ”), time-and-materials (“ T&M ”), and cost-reimbursable contracts.
Under the percentage-of-completion cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation(s). Our cost estimation process is based on the professional knowledge of our professionals and draws on their significant experience and judgment.
Under the percentage-of-completion cost-to-cost measure of progress, the extent of progress towards completion is measured based on the ratio of costs incurred to date to the total estimated costs to complete the performance obligation(s). 84 Table of Contents Our cost estimation process is based on the professional knowledge of our professionals and draws on their significant experience and judgment.
The number of Discretionary PSUs and STIP PSUs that will vest is based on the achievement of the performance criteria during each respective annual measurement period, provided that the employees remain 88 Table of Contents in continuous service on each vesting date. Vesting will not occur unless a minimum performance criteria threshold is achieved.
The number of Discretionary PSUs and STIP PSUs that will vest is based on the achievement of the performance criteria during each respective annual measurement period, provided that the employees remain in continuous service on each vesting date. Vesting will not occur unless a minimum performance criteria threshold is achieved.
Based on our projected cash flow and liquidity needs, we believe that our cash from operating activities generated from continuing operations during the year will be adequate for the next 12 months to meet our anticipated uses of cash flow.
Based on our projected cash flow and liquidity needs, we believe that our cash from operating activities generated from continuing operations 77 Table of Contents during the year will be adequate for the next 12 months to meet our anticipated uses of cash flow.
In consideration for the immediate and full exercise of the existing warrant for cash, the investor received a new unregistered Common Stock Purchase Warrant to purchase up to an aggregate of 3,770,000 shares of the Company’s common stock (the “New Warrant”) in a private placement.
In consideration for the immediate and full exercise of the existing warrant for cash, the investor received a new unregistered Common Stock Purchase Warrant to purchase up to an aggregate of 3,770,000 shares of the Company’s common stock (the “2025 RDO Warrant”) in a private placement.
The favorable change in net working capital was largely driven by a decrease in accounts receivable of $6.4 million, a decrease in prepaid expenses and other assets of $5.9 82 Table of Contents million, and in increase in accrued liabilities of $2.6 million.
The favorable change in net working capital was largely driven by a decrease in accounts receivable of $6.4 million, a decrease in prepaid expenses and other assets of $5.9 million, and in increase in accrued liabilities of $2.6 million.
The Company recognized a loss on extinguishment of $31.3 million on the consolidated statements of operations related to the unamortized debt issuance costs of the exchanged 2026 Convertible Notes. The 2029 Convertible Notes were issued pursuant to, and are governed by, an indenture, dated as of December 27, 2024.
The Company recognized a loss on extinguishment of $31.3 million on the consolidated statements of operations and comprehensive loss related to the unamortized debt issuance costs of the exchanged 2026 Convertible Notes during the year ended December 31, 2024. The 2029 Convertible Notes were issued pursuant to, and are governed by, an indenture, dated as of December 27, 2024.
We assess goodwill for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. For the purposes of impairment testing, we have determined that we have two reporting units.
We assess goodwill for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. For the purposes of impairment testing, we have determined that we have one reporting unit.
Specifically, judgment is used in interpreting complex arrangements with nonstandard terms and conditions and determining when all criteria for revenue recognition have been met. The Company’s revenues are derived from the sale of artificial intelligence, machine learning, and technical consulting solutions and services.
Revenue Recognition The recognition and measurement of revenue requires the use of judgments and estimates. Specifically, judgment is used in interpreting complex arrangements with nonstandard terms and conditions and determining when all criteria for revenue recognition have been met. The Company’s revenues are derived from the sale of artificial intelligence, machine learning, and technical consulting solutions and services.
We continue to expect the geopolitical climate to drive adoption of our offerings over the long term, as it has heightened the need for advanced AI tools that provide enhanced intelligence and full spectrum cyber operations – areas where we have unmatched capabilities.
We continue to expect the global economic and geopolitical environment to drive adoption of our offerings over the long term, as it has heightened the need for advanced AI tools that provide enhanced intelligence and full spectrum cyber operations – areas where we believe we have unmatched capabilities.
The effective 75 Table of Contents tax rate for the year ended December 31, 2024 differs from the U.S. federal income tax rate of 21.0% primarily due to state and local income taxes, permanent differences between book and taxable income, certain discrete items and the change in valuation allowance.
The effective tax rate for the year ended December 31, 2025 differs from the U.S. federal income tax rate of 21.0% primarily due to state and local income taxes, permanent differences between book and taxable income, certain discrete items and the change in valuation allowance.
(7) Non-recurring internal integration costs related to the Pangiam acquisition. (8) During the year ended December 31, 2024, the Company recognized a non-cash goodwill impairment charge primarily driven by a decrease in share price during the quarter compared to the share price of the equity issued as consideration for the purchase of Pangiam.
(7) Non-recurring internal integration costs related to the Pangiam and Ask Sage acquisitions, respectively. (8) During the year ended December 31, 2024, the Company recognized a non-cash goodwill impairment charge primarily driven by a decrease in share price during the quarter compared to the share price of the equity issued as consideration for the purchase of Pangiam.
The 2023 PIPE warrants and the 2023 RDO warrant were fully settled as of December 31, 2024 . The net increase in fair value of derivatives of $7.4 million for the year ended December 31, 2023 consists of fair value remeasurements of IPO private warrants, 2026 Notes Conversion Option, PIPE warrants, and RDO warrants.
The net increase in fair value of derivatives of $107.7 million for the year ended December 31, 2024 includes fair value remeasurements of the 2026 Notes Conversion Option, 2029 Notes Conversion Option, IPO private warrants, PIPE warrants, and RDO warrants. The 2023 PIPE warrants and the 2023 RDO warrant were fully settled as of December 31, 2024.
The Company exchanged (the “ Exchange Transaction ”) approximately $182.3 million principal amount of the 2026 Convertible Notes for $182.3 million in aggregate principal amount of the Company’s 2029 Convertible Notes and approximately $0.4 million in cash, with such cash payment representing the accrued and unpaid interest on such the exchanged 2026 Convertible Notes.
The Company exchanged (the “ Exchange Transaction ”) approximately $182.3 million principal amount of the 2026 Convertible Notes for $182.3 million in aggregate principal amount of the Company’s 2029 Convertible Notes and 79 Table of Contents approximately $0.4 million in cash, with such cash payment representing the accrued and unpaid interest on such then existing Convertible Notes.
The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable.
The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. The Company previously elected not to opt out of the extended transition period.
The approaches used for determining the fair value of finite-lived technology and customer relationships acquired depends on the circumstances; the Company has used the income approach (within the income approach, various methods are available such as multi-period excess earnings, with and without, incremental and relief from royalty methods).
The approaches used for determining the fair value of finite-lived intangible assets depends on the circumstances; the Company has used the income approach (within the income approach, various methods are available such as multi-period excess earnings, with and without, incremental and relief from royalty methods).
The decrease in cost of revenues as a percentage of total revenues was driven by higher margins from the inclusion of Pangiam’s results. Cost of revenues as a percentage of total revenues increased to 74% for the year ended December 31, 2023 as compared to 77% for the year ended December 31, 2022.
Cost of revenues as a percentage of total revenues was 71% for the year ended December 31, 2024 as compared to 74% for the year ended December 31, 2023. The decrease in cost of revenues as a percentage of total revenues was driven by higher margins from the inclusion of Pangiam’s results.
Adjusted EBITDA is defined as net income (loss) adjusted for interest expense (incom e), net, income tax (benefit) expense, depreciation and amortization, equity-based compensation and associated employer payroll taxes, net increase in fair value of derivatives, restructuring charges, non-recurring strategic initiatives, non-recurring litigation, transaction expenses, goodwill impairment, non-recurring integration costs, capital market advisory fees, commercial start-up costs, and loss on extinguishment of debt.
Adjusted EBITDA is defined as net loss adjusted for interest expense, interest income, income tax benefit, depreciation and amortization, equity-based compensation and associated employer payroll taxes, net increase in fair value of derivatives, restructuring charges, non-recurring strategic initiatives, non-recurring litigation, transaction expenses, non-recurring integration costs, goodwill impairment, and loss on extinguishment of debt.
As of January 1, 2025, the Company reserved an aggregate of 3,316,677 common shares (subject to annual increases on January 1 of each year and ending in 2031) of the Company’s common stock for grants under the ESPP.
As of January 1, 2025, the Company reserved an aggregate of 5,260,346 common shares (subject to annual increases on January 1 of each year and ending in 2031) of the Company’s common stock for grants under the ESPP.
The additional loss relates to $11.4 million fair market value adjustment of the 2026 Notes Conversion Option, 2024 Warrants, and IPO Private Warrants during the year ended December 31, 2024.This loss is net of a $10.6 million gain related to the issuance of the 2024 Warrants and was further offset by a reduction of $11.4 million upon remeasurement of the 2024 Warrants and IPO Private Warrants’ fair value during the year ended December 31, 2024.
This loss is net of a $10.6 million gain related to the issuance of the 2024 Warrants and was further offset by a reduction of $11.4 million upon remeasurement of the 2024 Warrants and IPO Private Warrants’ fair value during the year ended December 31, 2024.
Equity-based compensation expense related to purchase rights issued under the ESPP is based on the Black-Scholes OPM fair value of the estimated number of awards as of the beginning of the offering period. Equity-based compensation expense is recognized using the straight-line method over the offering period.
Equity-based compensation expense related to purchase rights issued under the ESPP is based on the Black-Scholes OPM fair value of the estimated number of awards as of the beginning of the offering period.
Goodwill Impairment Year Ended December 31, Year-Over-Year Change 2024 2023 2022 2024 vs 2023 2023 vs 2022 Goodwill impairment $ 85,000 $ — $ 53,544 $ 85,000 100.0 % $ (53,544) (100.0) % During the year ended December 31, 2024, the Company recognized a non-cash goodwill impairment charge of $85.0 million primarily driven by a decrease in share price during the quarter compared to the share price of the equity issued as consideration for the acquisition of Pangiam.
During the year ended December 31, 2024, the Company recognized a non-cash goodwill impairment charge of $85.0 million primarily driven by a decrease in share price during the first quarter of 2024 compared to the share price of the equity issued as consideration for the acquisition of Pangiam.
The table below presents a reconciliation of free cash flow to net cash used in operating activities, computed in accordance with GAAP: Year Ended December 31, 2024 2023 2022 Net cash used in operating activities $ (38,119) $ (18,307) $ (48,918) Capital expenditures, net (11,114) (3,830) (769) Free cash flow $ (49,233) $ (22,137) $ (49,687) Key Performance Indicators Backlog We view growth in backlog as a key measure of our business growth.
The table below presents a reconciliation of free cash flow to net cash used in operating activities, computed in accordance with GAAP: Years Ended December 31, 2025 2024 2023 Net cash used in operating activities $ (41,951) $ (38,119) $ (18,307) Capital expenditures, net (4,366) (11,114) (3,830) Free cash flow $ (46,317) $ (49,233) $ (22,137) Key Performance Indicators Backlog We view growth in backlog as a key measure of our business growth.
The 2029 Convertible Notes added a covenant that require the Company to maintain liquidity of at least $15 million measured as an average of the last five business days of any month. As of December 31, 2024, the Company was in compliance with all covenants related to the Convertible Notes.
The 2029 Convertible Notes added a covenant that requires the Company to maintain liquidity of at least $15 million measured as of the last business day of any month. As of December 31, 2025, the Company was in compliance with all covenants related to the Convertible Notes.
Income Taxes Significant judgments are required in order to determine the realizability of tax assets. In assessing the need for a valuation allowance, we evaluate all significant available positive and negative evidence, including historical operating results, estimates of future sources of taxable income, carry-forward periods available, the existence of prudent and feasible tax planning strategies and other relevant factors.
In assessing the need for a valuation allowance, we evaluate all significant available positive and negative evidence, including historical operating results, estimates of future sources of taxable income, carry-forward periods available, the existence of prudent and feasible tax planning strategies and 85 Table of Contents other relevant factors.
The stock options expire on the 10th anniversary of the grant date. The Company recognizes equity-based compensation expense for the stock options equal to the fair value of the awards on a straight-line basis over the service based vesting period. Restricted Stock Units Pursuant to the Plan, the Company may award Restricted Stock Units (“ RSUs ”) to eligible employees.
The stock options expire on the 10th anniversary of the grant date. The Company recognizes equity-based compensation expense for the stock options equal to the fair value of the awards on a straight-line basis over the service based vesting period.
Goodwill Impairment Goodwill impairment consists of non-cash impairments of goodwill. Net Increase (Decrease) in Fair Value of Derivatives Net increase (decrease) in fair value of derivatives consists of fair value remeasurements of the 2029 Convertible Notes Conversion Option, 2026 Convertible Notes Conversion Option, PIPE warrants, RDO warrants, IPO private warrants, and the Written put option.
Net increase in fair value of derivatives Net increase in fair value of derivatives consists of fair value remeasurements of the 2029 Convertible Notes Conversion Option, 2026 Convertible Notes Conversion Option, PIPE warrants, RDO warrants, and IPO private warrants.
(2) The increase in fair value of derivatives during the year ended December 31, 2024, relates to the $42.3 million loss recorded upon the exercise of the 2023 RDO and 2023 PIPE Warrants (the “2023 Warrants”) and issuance of the warrants in 2024 (the “2024 Warrants”) in connection with the warrant exercise agreements entered into on February 27, 2024 and March 4, 2024.
Additionally, there was a loss of $20.8 million fair market value adjustments of the 2026 and 2029 Notes Conversion Option, during the year ended December 31, 2025. 75 Table of Contents (2) The increase in fair value of derivatives during the year ended December 31, 2024, relates to the $42.3 million loss recorded upon the exercise of the 2023 RDO and 2023 PIPE Warrants (the “2023 Warrants”) and issuance of the warrants in 2024 (the “2024 Warrants”) in connection with the warrant exercise agreements entered into on February 27, 2024 and March 4, 2024.
The fair value of the acquired technology and customer relationships has been estimated using various underlying judgments, assumptions, and estimates. Potential changes in the underlying judgments, assumptions, and estimates used in our valuations of acquired intangible assets could result in different estimates of the future fair values.
Potential changes in the underlying judgments, assumptions, and estimates used in our valuations of acquired intangible assets could result in different estimates of the future fair values.
The Company did not receive any cash proceeds from the issuance of the 2029 Convertible Notes pursuant to the Exchange Transactions. The 2026 Convertible Notes and the 2029 Convertible Notes require the Company to meet certain financial and other covenants.
Upon completion of the Exchange Transaction, the aggregate principal amount of the 2026 Convertible Notes outstanding was $17.7 million . The Company did not receive any cash proceeds from the issuance of the 2029 Convertible Notes pursuant to the Exchange Transactions. The 2026 Convertible Notes and the 2029 Convertible Notes require the Company to meet certain financial and other covenants.
These were partially offset by an increase in contract assets of $3.5 million, a decrease in accounts payable of $4.4 million, a decrease in contract liabilities of $1.1 million, and a decrease in other liabilities of $2.3 million. For the year ended December 31, 2022, net cash used in operating activities was $48.9 million.
These were partially offset by an increase in prepaid expenses and other assets of $10.4 million, a decrease in accounts payable of $5.7 million, and a decrease in accrued expenses of $0.3 million. For the year ended December 31, 2024, net cash used in operating activities was $38.1 million.
The change in revenues were primarily driven by increases due to the acquisition of Pangiam, offset by decreased volume from the Air Force EPASS program which wound down in the second quarter of 2023.
Revenues increased by $3.1 million during the year ended December 31, 2024 as compared to the year ended December 31, 2023. The change in revenues were primarily driven by increases due to the acquisition of Pangiam, offset by decreased volume from the Air Force EPASS program which wound down in the second quarter of 2023.
The 2029 Convertible Notes will be fully and unconditionally guaranteed, on a senior, secured basis, by the Company and certain of its existing and future direct and indirect subsidiaries, subject to certain exceptions (the “Guarantors”), and will initially be secured on a first-priority basis by substantially all assets of the Company and such Guarantors, subject to certain exceptions. 80 Table of Contents Upon completion of the Exchange Transaction, the aggregate principal amount of the 2026 Convertible Notes outstanding was $17.7 million.
The 2029 Convertible Notes will be fully and unconditionally guaranteed, on a senior, secured basis, by the Company and certain of its existing and future direct and indirect subsidiaries, subject to certain exceptions (the “Guarantors”), and will initially be secured on a first-priority basis by substantially all assets of the Company and such Guarantors, subject to certain exceptions.
For the year ended December 31, 2023, net cash provided by financing activities was $42.1 million, primarily consisting of net proceeds from the issuance of the Private Placement and Registered Direct Offering shares of $50.0 million, offset by the payment of transaction costs associated with the Private Placement and Registered Direct Offering of $5.7 million, proceeds from the issuance of common stock upon ESPP purchase of $1.2 million, the payment of taxes related to net share settlement of equity awards of $2.6 million, and net repayment of $0.8 million related to the 2023 D&O Financing Loan.
For the year ended December 31, 2023, net cash provided by financing activities was $42.1 million, primarily consisting of net proceeds from the issuance of the Private Placement and Registered Direct Offering shares of $50.0 million, offset by the payment of transaction costs associated with the Private Placement and Registered Direct Offering of $5.7 million, proceeds from the issuance of common stock upon ESPP purchase of $1.2 million, the payment of taxes related to net share settlement of equity awards of $2.6 million, and net repayment of $0.8 million related to the 2023 D&O Financing Loan. 81 Table of Contents Critical Accounting Policies and Estimates Our significant accounting policies are summarized in Note 2 of our audited consolidated financial statements for the year ended December 31, 2025 included in this Annual Report on Form 10-K.
Interest Expense Year Ended December 31, Year-Over-Year Change 2024 2023 (as restated) 2022 (as restated) 2024 vs 2023 2023 vs 2022 (as restated) Interest expense $ 25,647 $ 24,877 $ 24,092 $ 770 3.1 % $ 785 3.3 % Interest expense during the years ended December 31, 2024, December 31, 2023, and December 31, 2022 consists primarily of interest expense, commitment fees, debt issuance discount amortization, and debt issuance cost amortization under our Convertible Notes and Bank of America Senior Revolver.
Interest expense Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 Interest expense $ 18,116 $ 25,647 $ 24,877 $ (7,531) (29.4) % $ 770 3.1 % Interest expense during the year ended December 31, 2025 and 2024 consists primarily of interest expense, debt issuance discount amortization, commitment fees and debt issuance cost amortization under our Convertible Notes.
Our quantitative goodwill impairment test reflected an allocation of 50% and 50% between the income and market-based approaches, respectively. Significant inputs into the valuation models included the discount rate, EBITDA growth and estimated future cash flows.
Our goodwill impairment test reflected an allocation of 50% and 50% between the income and market-based approaches, respectively. Significant inputs into the valuation models included the discount rate, EBITDA growth and estimated future cash flows. We used a discount rate of 12%, guideline peer group and their historical and forward-looking revenues in the goodwill impairment test.
(3) During the year ended December 31, 2024 and the year ended December 31, 2023, the Company incurred employee separation costs associated with a strategic review of the Company’s capacity and future projections to better align the organization and cost structure and improve the affordability of its products and services.
(3) Employee separation costs associated with strategic reviews of the Company’s capacity and future projections to better align the organization and cost structure and improve the affordability of its products and services.
Net Increase (Decrease) in Fair Value of Derivatives Year Ended December 31, Year-Over-Year Change 2024 2023 (as restated) 2022 (as restated) 2024 vs 2023 2023 vs 2022 (as restated) Net increase (decrease) in fair value of derivatives $ 107,658 $ 7,361 $ (21,387) $ 100,297 1362.5 % $ 28,748 (134.4) % The net increase in fair value of derivatives of $107.7 million for the year ended December 31, 2024 includes fair value remeasurements of the 2026 Notes Conversion Option, 2029 Notes Conversion Option, IPO private warrants, PIPE warrants, and RDO warrants.
Net increase in fair value of derivatives Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 Net increase in fair value of derivatives $ 92,794 $ 107,658 $ 7,361 $ (14,864) (13.8) % $ 100,297 1362.5 % The net increase in fair value of derivatives of $92.8 million for the year ended December 31, 2025 includes fair value remeasurements of the 2029 Notes Conversion Option, IPO private warrants, 2026 Notes Conversion Option, and the 2025 RDO warrants.
The 2024 RDO warrants became exercisable commencing on August 28, 2024, expiring after five years, with an exercise price per share equal to $3.78. These warrants were fully exercised during the first quarter of 2025.
The 2024 RDO warrants became exercisable six months after issuance and had a five-year term, with an exercise price per share equal to $3.78. These warrants were fully exercised during the first quarter of 2025.
These increases were partially offset by an increase in accounts receivable of $0.8 million, an increase in prepaid expenses and other assets of $1.7 million, a decrease in accrued liabilities of $5.1 million and a decrease in contract liabilities of $3.7 million.
These were partially offset by an increase in contract assets of $3.5 million, a decrease in accounts payable of $4.4 million, a decrease in contract liabilities of $1.1 million, and a decrease in other liabilities of $2.3 million.
SG&A Year Ended December 31, Year-Over-Year Change 2024 2023 2022 2024 vs 2023 2023 vs 2022 SG&A $ 80,040 $ 71,057 $ 84,775 $ 8,983 12.6 % $ (13,718) (16.2) % SG&A as a percentage of revenues 51 % 46 % 55 % SG&A expenses as a percentage of total revenues for the year ended December 31, 2024 increased to 51% as compared to 46% for the year ended December 31, 2023.
SG&A Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 SG&A $ 95,132 $ 80,040 $ 71,057 $ 15,092 18.9 % $ 8,983 12.6 % SG&A as a percentage of revenues 75 % 51 % 46 % SG&A expenses as a percentage of total revenues for the year ended December 31, 2025 increased to 75% as compared to 51% for the year ended December 31, 2024.
Research and Development Year Ended December 31, Year-Over-Year Change 2024 2023 2022 2024 vs 2023 2023 vs 2022 Research and development $ 10,863 $ 5,035 $ 8,393 $ 5,828 115.7 % $ (3,358) (40.0) % Research and development expenses increased by $5.8 million during the year ended December 31, 2024 as compared to the year ended December 31, 2023.
Research and development Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 Research and development $ 16,752 $ 10,863 $ 5,035 $ 5,889 54.2 % $ 5,828 115.7 % Research and development expenses increased by $5.9 million during the year ended December 31, 2025 as compared to the year ended December 31, 2024.
Interest Expense Interest expense consists primarily of interest expense, commitment fees, debt issuance discount amortization, and debt issuance cost amortization under our debt agreements.
Interest expense Interest expense consists primarily of interest expense, commitment fees, debt issuance discount amortization, and debt issuance cost amortization under our debt agreements. Interest income Interest income consists primarily of interest income earned on our money market accounts and investments in debt securities.
Additionally, for the year-ended December 31, 2024, $54.4 million is related to derivative liabilities in connection with the 2029 Convertible Notes. The increase in fair value of derivatives during the year ended December 31, 2023 primarily relates to changes in the fair value of PIPE warrant and RDO warrants issued during the first and second quarters of 2023.
The increase in fair value of derivatives during the year ended December 31, 2023 primarily relates to changes in the fair value of PIPE warrant and RDO warrants issued during the first and second quarters of 2023.
(6) Transaction expenses during the year ended December 31, 2024 and December 31, 2023 consist primarily of diligence, legal and other related expenses incurred associated with the Pangiam acquisition. Transaction costs incurred in 2022 are primarily related to our acquisition of ProModel Corporation as well as costs associated with evaluating other acquisition opportunities.
(6) Transaction expenses during the year ended December 31, 2024 consist primarily of diligence, legal and other related expenses incurred associated with the Pangiam acquisition. Transaction expenses during the year ended December 31, 2025 consist primarily of diligence, legal and other related expenses incurred associated with the Ask Sage acquisition, as well as expenses incurred to explore other acquisition options.
Cash Flows The table below summarizes certain information from our consolidated statements of cash flows for the following periods: Year Ended December 31, 2024 2023 2022 Net cash used in operating activities (38,119) (18,307) (48,918) Net cash provided by (used in) investing activities 2,821 (3,830) (5,234) Net cash provided by (used in) financing activities 52,458 42,062 (103,137) Net increase (decrease) in cash and cash equivalents 17,584 19,925 (157,289) Cash and cash equivalents at the beginning of period 32,557 12,632 169,921 Cash and cash equivalents at the end of the period $ 50,141 $ 32,557 $ 12,632 Operating activities For the year ended December 31, 2024, net cash used in operating activities was $38.1 million.
Cash Flows The table below summarizes certain information from our consolidated statements of cash flows for the following periods: Years Ended December 31, 2025 2024 2023 Net cash used in operating activities $ (41,951) $ (38,119) $ (18,307) Net cash (used in) provided by investing activities (606,682) 2,821 (3,830) Net cash provided by financing activities 691,313 52,458 42,062 Effect of foreign currency rate changes on cash and cash equivalents (174) 424 — Net increase in cash, cash equivalents, and restricted cash 42,506 17,584 19,925 Cash, cash equivalents, and restricted cash at the beginning of the period 50,141 32,557 12,632 Cash, cash equivalents, and restricted cash at the end of the period $ 92,647 $ 50,141 $ 32,557 80 Table of Contents Operating activities For the year ended December 31, 2025, net cash used in operating activities was $42.0 million.
Because not all companies use identical calculations, our presentation of non-GAAP measures may not be comparable to other similarly titled measures of other companies. 76 Table of Contents Adjusted EBITDA - Non-GAAP The following table presents a reconciliation of Adjusted EBITDA to net loss, computed in accordance with GAAP: Year Ended December 31, 2024 2023 (as restated) 2022 (as restated) Net loss $ (295,547) $ (70,657) $ (111,367) Interest expense 25,647 24,877 24,092 Interest income (2,293) (392) — Income tax benefit (256) (222) (1,884) Depreciation and amortization 11,872 7,901 7,758 EBITDA (260,577) (38,493) (81,401) Adjustments: Equity-based compensation 21,127 18,671 10,865 Employer payroll taxes related to equity-based compensation (1) 985 440 — Net increase in fair value of derivatives (2) 107,658 7,361 (21,387) Restructuring charges (3) 1,287 822 4,203 Non-recurring strategic initiatives (4) 6,459 3,025 — Non-recurring litigation (5) 1,142 2,250 — Transaction expenses (6) 1,450 2,721 2,605 Non-recurring integration costs (7) 1,800 — — Goodwill impairment (8) 85,000 — 53,544 Loss on extinguishment of debt (9) 31,272 — — Capital market advisory fees (10) — — 741 Commercial start-up costs (11) — — 6,490 Adjusted EBITDA $ (2,397) $ (3,203) $ (17,085) (1) Includes employer payroll taxes due upon the vesting of equity awards granted to employees.
Adjusted EBITDA - Non-GAAP The following table presents a reconciliation of Adjusted EBITDA to net loss, computed in accordance with GAAP: Years Ended December 31, 2025 2024 2023 Net loss $ (293,914) $ (295,547) $ (70,657) Interest expense 18,116 25,647 24,877 Interest income (13,253) (2,293) (392) Income tax benefit (21,722) (256) (222) Depreciation and amortization 15,281 11,872 7,901 EBITDA (295,492) (260,577) (38,493) Adjustments: Equity-based compensation 23,330 21,127 18,671 Employer payroll taxes related to equity-based compensation (1) 2,011 985 440 Net increase in fair value of derivatives (2) 92,794 107,658 7,361 Restructuring charges (3) 4,370 1,287 822 Non-recurring strategic initiatives (4) 9,075 6,459 3,025 Non-recurring litigation (5) 30 1,142 2,250 Transaction expenses (6) 2,082 1,450 2,721 Non-recurring integration costs (7) 44 1,800 — Goodwill impairment (8) 70,636 85,000 — Impairment of long-lived assets (9) 53,403 — — Loss on extinguishment of debt (10) 2,577 31,272 — Adjusted EBITDA $ (35,140) $ (2,397) $ (3,203) (1) Includes employer payroll taxes due upon the vesting of equity awards granted to employees.
Unpriced unexercised contract options represent the remaining contract value of goods and services to be delivered under existing contracts if our customer elects to exercise all of the options available in the contract.
Unpriced unexercised contract options represent the remaining contract value of goods and services to be delivered under existing contracts if our customer elects to exercise all of the options available in the contract. For unpriced unexercised options, we estimate backlog generally under the assumption that our current level of support on the contract will persist for each option period.
The increase in research and development expenses was driven by increased headcount, the timing of certain research and development projects, as well as the inclusion of Pangiam’s results. Research and development expenses decreased by $3.4 million during the year ended December 31, 2023 as compared to the year ended December 31, 2022.
The increase in research and development expenses was driven by increased headcount, the timing of certain research and development projects, as well as the inclusion of Pangiam’s results.
Cost of Revenues Year Ended December 31, Year-Over-Year Change 2024 2023 2022 2024 vs 2023 2023 vs 2022 Cost of revenues $ 113,016 $ 114,563 $ 111,510 $ (1,547) (1.4) % $ 2,545 2.3 % Cost of revenues as a percentage of revenues 71 % 74 % 77 % Cost of revenues as a percentage of total revenues was 71% for the year ended December 31, 2024 as compared to 74% for the year ended December 31, 2023.
Cost of revenues Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 Cost of revenues $ 99,194 $ 113,016 $ 114,563 $ (13,822) (12.2) % $ (1,547) (1.4) % Cost of revenues as a percentage of revenues 78 % 71 % 74 % Cost of revenues as a percentage of total revenues was 78% and 71% for the year ended December 31, 2025 and 2024, respectively.
Restructuring Charges Restructuring charges consist of employee separation costs and impairment of lease right-of-use assets related to strategic cost saving initiatives to better align our organization and cost structure and improve the affordability of our products and services.
Restructuring charges Restructuring charges consist of employee separation costs related to strategic cost saving initiatives to better align our organization and cost structure and improve the affordability of our products and services as well as employee separation costs associated with strategic changes in certain key leadership roles.
Because the fair value of the reporting unit approximated its carrying value, a negative change in the key assumptions used in the interim impairment analysis or an increase in the carrying value may result in a future impairment of goodwill.
Due to the proximity of the long-lived asset impairment and the acquisition of Ask Sage, the fair value of the reporting unit approximates its carrying value, and a negative change in the key assumptions used in the interim impairment analysis and the purchase price allocation or an increase in the carrying value may result in a future impairment of goodwill.
The conversion rate is 281.4491 shares of common stock per $1,000 principal amount of 2029 Convertible Notes, which represents an initial conversion price of $3.55 per share of the Company’s common stock.
The conversion rate is 281.4491 shares of common stock per $1,000 principal amount of 2029 Convertible Notes, which represents an initial conversion price of $3.55 per share of the Company’s common stock. During the three months ended March 31, 2025, $57.7 million of the 2029 Convertible Notes were voluntarily converted by noteholders following the Exchange Transaction.
Our primary short-term cash requirements are to fund payroll obligations, working capital, operating lease obligations, interest payments and short-term debt, including current maturities of long-term debt. Working capital requirements can vary significantly from period to period, particularly as a result of the timing of receipts and disbursements related to long-term contracts.
Working capital requirements can vary significantly from period to period, particularly as a result of the timing of receipts and disbursements related to long-term contracts.
The following table summarizes certain backlog information: December 31, 2024 December 31, 2023 Funded $ 46,552 $ 30,112 Unfunded 72,474 49,382 Priced, unexercised options 283,258 63,878 Unpriced, unexercised options 16,021 24,438 Total backlog $ 418,305 $ 167,810 Liquidity and Capital Resources Our primary sources of liquidity are cash flows provided by our operations.
The following table summarizes certain backlog information (in thousands): December 31, 2025 December 31, 2024 Funded $ 54,859 $ 46,552 Unfunded 57,509 72,474 Priced, unexercised options 130,564 283,258 Unpriced, unexercised options 5,128 16,021 Total backlog $ 248,060 $ 418,305 Liquidity and Capital Resources Sources of Liquidity Our primary sources of liquidity are cash flows provided by our operations and maturities of available-for-sale investments.
Recent Accounting Pronouncements See Note 3—Summary of Significant Accounting Policies of the consolidated financial statements included in this Annual Report on Form 10-K for a discussion of recently issued accounting pronouncements.
However, as of December 31, 2025, the Company has adopted all applicable accounting standards effective for non-EGC filers as required. See Note 2—Summary of Significant Accounting Policies of the consolidated financial statements included in this Annual Report on Form 10-K for a discussion of recently issued accounting pronouncements.
As of December 31, 2024, the Company has determined that it is not more-likely-than-not that substantially all of its deferred tax assets will be realized in the future and continues to have a full valuation allowance established against its deferred tax assets.
The decrease in the effective tax rate for the year ended December 31, 2024 from the year ended December 31, 2023 was primarily due to significant pre-tax loss, non-deductible goodwill impairment and derivative losses, largely offset by an increase in valuation allowance. 74 Table of Contents As of December 31, 2025, the Company has determined that it is not more-likely-than-not that substantially all of its deferred tax assets will be realized in the future and continues to have a full valuation allowance established against its deferred tax assets.
The New Warrant will become exercisable commencing any time on or after August 6, 2025 (the “Exercise Date”) with an expiration date five years after the Exercise Date with an exercise price per share equal to $9.00. The gross proceeds to the Company from the exercise were $21.9 million, prior to deducting estimated offering expenses.
The 2025 RDO Warrant became exercisable commencing on August 6, 2025 (the “Exercise Date”) with an expiration date five years after the Exercise Date with an exercise price per share equal to $9.00.
Net loss before deducting depreciation, amortization and other non-cash items was $49.4 million and was offset by a favorable change in net working capital of $0.5 million which contributed to operating cash flows during this period. The favorable change in net working capital was largely driven by increases in accounts payable of $9.9 million and other liabilities of $2.2 million.
Net loss before deducting depreciation, amortization and other non-cash items was $46.9 million and was further impacted by a favorable change in net working capital of $5.0 million.
Transaction Expenses Year Ended December 31, Year-Over-Year Change 2024 2023 2022 2024 vs 2023 2023 vs 2022 Transaction expenses $ 1,450 $ 2,721 $ 2,605 $ (1,271) (46.7) % $ 116 4.5 % Transaction expenses for the years ended December 31, 2024 and December 31, 2023 consist of diligence, legal and other related expenses associated with the Pangiam Acquisition. 74 Table of Contents Transaction expenses the year ended December 31, 2022 are related to our acquisition of ProModel Corporation as well as costs associated with evaluating other acquisition opportunities.
Restructuring charges consist of employee separation costs related to strategic cost saving initiatives to better align our organization and cost structure and improve the affordability of our products and services as well as employee separation costs associated with strategic changes in certain key leadership roles 72 Table of Contents Transaction expenses Years Ended December 31, Year-Over-Year Change Year-Over-Year Change 2025 2024 2023 2025 vs 2024 2024 vs 2023 Transaction expenses $ 2,082 $ 1,450 $ 2,721 $ 632 43.6 % $ (1,271) (46.7) % Transaction expenses for the year ended December 31, 2025 consist of diligence, legal and other related expenses associated with the Ask Sage Acquisition, as well as costs associated with evaluating other acquisition opportunities .
If our assumptions or conditions change, the actual results the Company reports may differ from these estimates.
If our assumptions or conditions change, the actual results the Company reports may differ from these estimates. We believe the following critical accounting policies affect the more significant estimates, assumptions, and judgments we use to prepare our consolidated financial statements.